Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Frontline Therapy of Diffuse Large B Cell Lymphoma in Adults ( 18 to 60 Years Old): Randomisation Between High Dose Chemotherapy With Rituximab and CHOP 14 -Rituximab. Multicentric Randomised Prospective Trial.

Next Previous
X
Search
Trial Profile

Frontline Therapy of Diffuse Large B Cell Lymphoma in Adults ( 18 to 60 Years Old): Randomisation Between High Dose Chemotherapy With Rituximab and CHOP 14 -Rituximab. Multicentric Randomised Prospective Trial.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 27 Jan 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rituximab (Primary) ; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Methotrexate; Prednisone; Vincristine
  • Indications Diffuse large B cell lymphoma
  • Focus Pharmacogenomic; Therapeutic Use

    • Most Recent Events

    • 14 Dec 2021 Results (n=123) assessing the circulating tumor DNA (ctDNA) concentration measured by an easy-to-collect and cost-effective method in the GOELAMS 075 de novo DLBCL patients, in regards of the two frontline treatments, presented at the 63rd American Society of Hematology Annual Meeting and Exposition.
    • 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology
    • 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top